PGF
GILD icon

Plan Group Financial’s Gilead Sciences GILD Stock Holding History

Plan Group Financial’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$343K Buy
2,717
+673
+33% +$88.7K 0.07% 160
2026
Q1 		$285K Buy
+2,044
New +$286K 0.07% 176

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Plan Group Financial's GILD Position: Q2 2026 in Review

Plan Group Financial increased its Gilead Sciences (GILD) stake by 33% in Q2 2026, buying an estimated $88.7K and bringing the position to 2,717 shares worth $343K. The position accounts for 0.07% of the portfolio, ranked #160.

Plan Group Financial first reported a position in GILD in Q1 2026 and has held it in 2 quarters since. 2,281 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Plan Group Financial held 2,717 shares of Gilead Sciences worth $343K as of Q2 2026.
  • Plan Group Financial bought 673 Gilead Sciences shares in Q2 2026, an estimated $88.7K.
  • Gilead Sciences made up 0.07% of Plan Group Financial's portfolio in Q2 2026, its #160 holding.
  • Plan Group Financial first reported a position in Gilead Sciences in Q1 2026 and has held it in 2 quarters since.
  • 2,281 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Plan Group Financial's 13F filing for Q2 2026, filed 3 Aug 2026.